早期原发性胆汁性肝硬化自身免疫性肝炎重叠综合征1例
出处
《临床荟萃》
CAS
北大核心
2008年第4期291-292,共2页
Clinical Focus
二级参考文献117
-
1[18]Heuman DM,Mills AS,McCall J,Hylemon PB,Pandak WM,Vlahcevic ZR.Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts.In vivo studies in the rat.Gastroenterology 1991; 100:203-211
-
2[19]Heuman DM,Pandak WM,Hylemon PB,Vlahcevic ZR.Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts:in vitro studies in rat hepatocytes and human erythrocytes.Hepatology 1991; 14:920-926
-
3[20]Ohiwa T,Katagiri K,Hoshino M,Hayakawa T,Nakai T.Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content.Hepatology 1993; 17:470-476
-
4[21]Deroubaix X,Coche T,Depiereux E,Feytmans E.Saturation of hepatic transport of taurocholate in rats in vivo.Am J Physiol1991; 260:G189-G196
-
5[22]Galan AI,Jimenez R,Munoz ME,Gonzalez J.Effects of ursodeoxycholate on maximal biliary secretion of bilirubin in the rat.Biochem Pharmacol 1990; 39:1175-1180
-
6[23]Jazrawi RP,de Caestecker JS,Goggin PM,Britten AJ,Joseph AE,Maxwell JD,Northfield TC.Kinetics of hepatic bile acid handling in cholestatic liver disease:effect of ursodeoxycholic acid.Gastroenterology 1994; 106:134-142
-
7[24]Poupon RE,Chretien Y,Poupon R,Paumgartner G.Serum bile acids in primary biliary cirrhosis:effect of ursodeoxycholic acid therapy.Hepatology 1993; 17:599-604
-
8[25]Heathcote EJ,Cauch-Dudek K,Walker V,Bailey RJ,Blendis LM,Ghent CN,Michieletti P,Minuk GY,Pappas SC,Scully LJ.The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.Hepatology 1994; 19:1149-1156
-
9[26]Lindor KD.Ursodiol for primary sclerosing cholangitis.Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.N Engl J Med 1997; 336:691-695
-
10[27]Poupon RE,Balkau B,Eschwege E,Poupon R.A multicenter,controlled trial of ursodiol for the treatment of primary biliary cirrhosis.UDCA-PBC Study Group.N Engl J Med 1991; 324:1548-1554
共引文献17
-
1Paolo Onori,Eugenio Gaudio,Antonio Franchitto,Gianfranco Alpini,Heather Francis.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes[J].World Journal of Gastrointestinal Pathophysiology,2010,1(2):38-49.
-
2李霄,金宁一,连海,陈立刚,孙丽丽,李萍.Apoptin基因对人胃癌细胞BGC-823的抑制效应及与凋亡信号转导的关系[J].世界华人消化杂志,2006,14(31):2991-2996. 被引量：4
-
3巫协宁.胃肠激素、雌激素和熊去氧胆酸对胆管细胞功能的调节和改善作用[J].肝脏,2006,11(6):408-410.
-
4谢正元,罗忠金,张吉翔.胆汁淤积诊治进展[J].世界华人消化杂志,2007,15(35):3669-3673. 被引量：2
-
5Ali Shorbagi,Yusuf Bayraktar.Primary sclerosing cholangitis-What is the difference between east and west?[J].World Journal of Gastroenterology,2008,14(25):3974-3981. 被引量：6
-
6Maria J Perez,Oscar Briz.Bile-acid-induced cell injury and protection[J].World Journal of Gastroenterology,2009,15(14):1677-1689. 被引量：59
-
7曾丽,邵勇.熊脱氧胆酸治疗妊娠期肝内胆汁淤积症的研究进展[J].中华妇产科杂志,2010,45(7):547-549. 被引量：13
-
8宋雪艾,宋梅,孙永强,张宁,张悦,任岳波,浦士彪,李建宇.胆汁淤积性肝病皮肤瘙痒患者中药冷敷的效果观察[J].护理学杂志,2013,28(19):33-35. 被引量：5
-
9朱珊玲,李祥金,黄爱霞.熊去氧胆酸治疗重度慢性乙型肝炎伴胆汁淤积的疗效观察[J].湖北科技学院学报（医学版）,2014,28(3):215-217. 被引量：1
-
10李玲,张光全,廖忠,吴先麟,谢亮,姚波,李静,蒲成容.34例胆管消失综合征的单中心诊疗经验[J].胃肠病学和肝病学杂志,2014,23(9):1104-1106. 被引量：6
-
1黄淑莉.原发性胆汁性肝硬化36例护理体会[J].临床合理用药杂志,2013,6(32):163-163. 被引量：5
-
2黄韵祝,杨文秀,任婷婷,邓松.血清脂蛋白(a)在恶性肿瘤中的临床意义[J].护士进修杂志,2009,24(2):109-110. 被引量：8
-
3王立清,刘燕敏.原发性胆汁性肝硬化20例的护理[J].中国误诊学杂志,2009,9(5):1149-1150. 被引量：3
-
4吴婉芳.生后25天排白陶土样大便,35天皮肤黄染[J].中国社区医师,2009,25(24):15-15.
-
5王燕儿,施云珍,李丽琴.护理干预对还原型谷胱甘肽治疗病毒性肝炎的影响[J].中国现代医生,2014,52(11):76-78. 被引量：2
-
6顾瑾.静脉滴注阿拓莫兰致喉痉挛1例护理体会[J].齐鲁护理杂志,2007,13(7):94-95.
-
7章文娟.阿拓奠兰致过敏反应1例护理报告[J].常州实用医学,2008,24(1):69-70.
-
8张欣松,叶菲,徐善芝.抗线粒体抗体(AMA)的测定研究[J].生物技术,1999,9(2):37-38.
-
9赵国瑞,李彩霞,赵大同.胸腹水中胆红素蛋白质测定对结核性癌性和肝硬化性胸腹水的鉴别诊断价值[J].上海医学检验杂志,1995,10(1):7-7. 被引量：2
-
10卓忠雄,高云华,杨浩,严鸿渝,刘政.硬化性胰腺炎超声显像及其病理基础[J].中华超声影像学杂志,1997,6(4):201-203. 被引量：2
